Researcher Fired Over Cell Fiasco
By Associated Press,
Associated Press
| 03. 21. 2006
SEOUL _ The scientist who stunned the medical world with claims that he had created the first cloned human embryos and extracted stem cells from them _ research later found to have been faked _ was fired Monday by South Korea's most prestigious university.
Seoul National University decided to dismiss Hwang Woo-suk after a disciplinary meeting, saying he and his co-workers caused the school to lose honor. Six other professors who worked with Hwang were either suspended or had their salaries cut, the school said.
Last month, the school suspended Hwang, 53, from teaching and conducting research as an interim disciplinary measure, but he had remained a professor.
"The professors fundamentally abandoned honesty and sincerity _ and caused the fall in the school's honor and the country's international confidence," the university said in a statement Monday.
Byun Chang-ku, dean of the school's academic affairs, said the committee had decided to fire Hwang because he "took overall responsibility as the lead author and played a leading role in writing the papers with fake facts and data."
Hwang rarely appears in public...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...